[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "High 005",
    "section": "",
    "text": "Click to go deeper on your your curiosity\n\n\n\n\n\n\n\n\n\n\n\n\nNewcare\n\n\nThe news about revolution that are solving Medicine’s challenges\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nChagpt and his Artificial intelligence will make us live longer\n\n\n\n\n\n\n\n\nJan 22, 2025\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nIs tech improving our healthcare journey?\n\n\n\n\n\n\n\n\nJan 21, 2025\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBitcoin like solutions and decentralized payments can help your healthcare’s balance\n\n\n\n\n\n\n\n\nJan 20, 2025\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nArtificial intelligence will improve your healthcare job routine\n\n\n\n\n\n\n\n\nJan 11, 2025\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAspirin Vs Cancer\n\n\n\n\n\n\n\n\nMay 23, 2024\n\n\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "posts/datah/medical_datactor/aspirin/index.html",
    "href": "posts/datah/medical_datactor/aspirin/index.html",
    "title": "Aspirin Vs Cancer",
    "section": "",
    "text": "The article:\n“It is a rather unexpected effect, because aspirin is mainly used as an anti-inflammatory drug,” says Marco Scarpa, a researcher at the University of Padova, and one of the authors of the study. As Scarpa notes, this study suggests that aspirin may be playing a slightly different role by stimulating the immune system’s surveillance response, which can then prevent or delay the progression of colorectal cancer.\nfull article here: (https://www.nationalgeographic.com/premium/article/aspirin-immune-system-detect-target-cancer-cells)"
  },
  {
    "objectID": "jobs.html",
    "href": "jobs.html",
    "title": "Let’s keep in touch to find solutions",
    "section": "",
    "text": "Affiliations and ongoing projects:\n\nWith you [today - future]\nStealth deeptech startup (Verona, IT) [2024 - ongoing]\nASST Ospedale Papa Giovanni XXIII di Bergamo [2024 - ongoing]\nMainz University (Mainz, DE) [2024 - Accomplished]\nPadua University with the department of: Cardiology - internal Medicine - Surgery - Oncology (Padua, IT) [2021 - ongoing]\n\nemail : bisturiep005@gmail.com"
  },
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "About High 0.05",
    "section": "",
    "text": "It all started with debates with University Professors where bottles were uncorked when the P-value of the analysis in progress was less than 0.05. At that moment smiles blossomed and above all we began to share, as the English say, the “High five” with researchers of every background and specialty from biologists to Medical Doctors. To dedicate even an additional dose to that magical number, the whole company declared his love by adopting the name of so loved P = 0.05. The need to further explore a multidisciplinary approach is since technology is just a tool that can became useful if it brings large-scale changes to everyday life and can identify concrete and high-impact fields of application."
  },
  {
    "objectID": "Chicche.html",
    "href": "Chicche.html",
    "title": "Chicche",
    "section": "",
    "text": "Here, we will walk through an example of performing GSEA in R…\nlibrary(clusterProfiler) # Example code for GSEA"
  },
  {
    "objectID": "Chicche.html#easy-gene-set-enrichment-analysis-in-r",
    "href": "Chicche.html#easy-gene-set-enrichment-analysis-in-r",
    "title": "Chicche",
    "section": "",
    "text": "Here, we will walk through an example of performing GSEA in R…\nlibrary(clusterProfiler) # Example code for GSEA"
  },
  {
    "objectID": "posts/datah/index.html",
    "href": "posts/datah/index.html",
    "title": "Newcare",
    "section": "",
    "text": "Chagpt and his Artificial intelligence will make us live longer\n\n\n\n\n\n\n\n\n\n\n\nJan 22, 2025\n\n\n\n\n\n\n\n\n\n\n\n\nIs tech improving our healthcare journey?\n\n\n\n\n\n\n\n\n\n\n\nJan 21, 2025\n\n\n\n\n\n\n\n\n\n\n\n\nBitcoin like solutions and decentralized payments can help your healthcare’s balance\n\n\n\n\n\n\n\n\n\n\n\nJan 20, 2025\n\n\n\n\n\n\n\n\n\n\n\n\nArtificial intelligence will improve your healthcare job routine\n\n\n\n\n\n\n\n\n\n\n\nJan 11, 2025\n\n\n\n\n\n\n\n\n\n\n\n\nAspirin Vs Cancer\n\n\n\n\n\n\n\n\n\n\n\nMay 23, 2024\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "posts/datah/medical_datactor/cardiology/index.html",
    "href": "posts/datah/medical_datactor/cardiology/index.html",
    "title": "Artificial intelligence will improve your healthcare job routine",
    "section": "",
    "text": "AI and Medical journey\nLLMs in medicine are nowadays super in hype. Or better, GenAI is super in hype. The last one is different from traditional AI in that it can generate content, such as summaries of text and answers to questions, rather than merely analyzing existing data. GenAI can definitively improve your work as healthcare professional since the goal is just to “removing the robot that is inside you to let you perform more human related task”. Hence the opportunity here of GenAI is just to manage exactly all the jobs that as healthcare professional you try to avoid every day to let you as much time as possible with patients. This since GenAI can empower your role, plus the patients to take a more active role in their healthcare. This since patients can use LLM-powered chatbots to interact with their EHR, prepare for appointments.\nWhile challenges exist, the benefits of GenAI are too significant to ignore, and it may revolutionize care delivery by automating tasks, improving patient self-management, and enhancing job satisfaction.\nBy actively engaging in the development and implementation of GenAI, and adopting a balanced approach that prioritizes safety and responsibility, we can explore its potential to transform the way we deliver cardiovascular care and ultimately improve patient outcomes."
  },
  {
    "objectID": "posts/datah/medical_datactor/bitcoin/index.html",
    "href": "posts/datah/medical_datactor/bitcoin/index.html",
    "title": "Bitcoin like solutions and decentralized payments can help your healthcare’s balance",
    "section": "",
    "text": "The Bitcoin era\nDifferent medical practices experience varying degrees of benefit from cryptocurrency adoption. Practices that primarily operate on a cash basis, such as outpatient clinics and those offering concierge or direct primary care (where patients pay a recurring fee for enhanced access), can enhance their modern image by accepting cryptocurrency. The growing field of medical tourism also stands to gain. For patients traveling from countries with unstable local currencies or unfavorable exchange rates, cryptocurrency offers a potentially stable and convenient alternative. For example, in El Salvador, Bitcoin is legal tender, and in Argentina, where inflation is high and dollar exchange rates fluctuate significantly, cryptocurrency can provide a way to navigate financial uncertainty.\nWhile credit cards are popular for their convenience, their transaction fees (typically 3-5%) can significantly impact a practice’s revenue. Cryptocurrency payment gateways, however, often have much lower fees, sometimes as low as 0.5%. In the context of rising inflation and shrinking profit margins in healthcare, this difference can be crucial for maintaining profitability.\nThe potential of smart contracts, self-executing agreements coded on the blockchain, is a key aspect of this technology. These contracts automate transactions and reduce the need for intermediaries. In healthcare, they could streamline billing by releasing payments automatically upon service completion, such as after a telemedicine appointment, saving time and minimizing disputes.\nSmart contracts can also improve regulatory compliance by embedding legal requirements directly into transactions, enhancing security and trust. While implementation requires technical expertise, the resulting transparency and efficiency can be valuable. For practices using cryptocurrency, smart contracts offer additional innovation and functionality.\nDirect cryptocurrency transfers between patient and practice wallets, while technically possible and fee-free, are prone to errors and generally not recommended. Instead, practices should use cryptocurrency payment gateways. These platforms, similar to credit card processors, bridge the gap between patient wallets and the practice’s bank account, adding security layers. These gateways often mitigate price volatility by locking in exchange rates for a short period during transactions.\nUpon receiving payment, the practice can choose to retain the cryptocurrency or convert it to traditional currency. Various gateways exist, each with different fees and supported cryptocurrencies. Some offer reduced or waived fees for premium memberships, which may be beneficial for practices with high cryptocurrency transaction volumes.\nTo begin accepting cryptocurrency, a practice can:\nCreate an account on a reputable and regulated cryptocurrency exchange (e.g., Coinbase, Binance). Integrate the chosen platform with their website or provide in-office QR codes for payments. Decide whether to hold cryptocurrency or convert it to traditional currency. Train staff to manage transactions and monitor payments using the platform’s interface. Many gateways, including Coinbase and PayPal, offer user-friendly app-based payment options.\nWhen choosing which cryptocurrencies to accept, it’s important to be aware of the risks, including the prevalence of fraudulent or unstable currencies. Starting with Bitcoin (BTC), the most widely accepted cryptocurrency with the largest market capitalization, is advisable. Another option is USD Coin (USDT), a stablecoin pegged to the US dollar, which simplifies conversion to traditional currency.\nEven major cryptocurrencies can fluctuate significantly in value. This can lead to patient dissatisfaction if the value changes substantially after a transaction. Therefore, obtaining informed consent from patients before accepting cryptocurrency payments and clearly explaining the potential for price volatility is crucial. It’s important to acknowledge that price fluctuations could benefit or disadvantage the patient.\nWhile cryptocurrency offers a promising payment option for healthcare, it’s unlikely to completely replace traditional methods. Practices should maintain their existing payment infrastructure. Further research is needed to determine the prevalence of cryptocurrency use in healthcare transactions.\nCryptocurrency represents a potential evolution in healthcare finance. By adopting this technology, practices can modernize, potentially improve patient satisfaction, and streamline operations. Whether a practice is cash-based and seeking cost reductions or a medical tourism provider aiming to expand its reach, cryptocurrency offers potential benefits. A measured approach, continuous learning, and adaptability are key as this technology continues to develop."
  },
  {
    "objectID": "posts/datah/medical_datactor/tech_challenge/index.html",
    "href": "posts/datah/medical_datactor/tech_challenge/index.html",
    "title": "Is tech improving our healthcare journey?",
    "section": "",
    "text": "Is tech improving our healthcare journey?\nThe integration of digital technologies in healthcare is an evolutionary process, marked by both advancements and initial challenges. While the introduction of new technologies can lead to temporary setbacks and integration hurdles, the healthcare sector is currently experiencing a transformative period where data and technologies like artificial intelligence (AI) are converging to enhance processes, capabilities, and, most importantly, patient care. The following outlines some significant shifts occurring in healthcare delivery and medication management within complex supply chains and hospital systems.\nFrom Basic Automation to Intelligent and Adaptive Assistance:\nThe 21st century has witnessed a surge in the adoption of automation in healthcare. However, early automation systems presented their own set of difficulties. While hospital pharmacies have realized certain efficiencies, these technologies have also introduced challenges, such as information overload.\nMany communication systems, designed with good intentions, may have been implemented without a comprehensive understanding of hospital workflows. This has resulted in excessive and often unnecessary communication, contributing to staff burnout, particularly in pharmacy settings where personnel are bombarded with irrelevant or low-value notifications. Consequently, there’s a critical need for more user-centric and adaptive systems.\nAI is paving the way for such systems, enabling greater customization based on individual user needs. Instead of being designed solely around a tool’s capabilities, features and notifications can be tailored to specific user requirements. This represents a significant advancement in hospital-based digital transformation, shifting the focus from simply having information available to optimizing how that information is accessed and utilized.\nThe importance of this customization becomes clear when considering the complex tasks healthcare professionals perform. For instance, an anesthesiologist in the operating room might be managing numerous concurrent tasks, including monitoring patient vitals, interacting with electronic health records (EHRs), and tracking medication administration. Currently, this information often originates from disparate sources. The goal is to consolidate and deliver this information to providers in a timely and relevant manner. The future envisions technology as an extension of the provider, potentially through innovations like virtual and augmented reality, providing real-time access to crucial information.\nEnhancing Supply Chain Management through Predictive Analytics and Collaboration:\nEffective pharmaceutical forecasting and management are essential for both operational efficiency and patient well-being. However, maintaining a balance between overstocking and stockouts can be challenging.\nDrug shortages remain a persistent problem in healthcare. Conversely, excessive stockpiling can lead to waste through expiration or unnecessary inventory costs. Machine learning (ML) offers a promising solution for supply chain optimization. Centralizing data by integrating technologies across health systems creates a unified data repository. This repository provides real-time visibility into inventory, usage trends, expirations, recalls, and other critical data points.\nBy leveraging this comprehensive data, ML algorithms can generate analytical insights and predictive models to anticipate future needs and optimize ordering processes. This allows for more efficient distribution of pharmaceuticals within hospital systems, freeing pharmacists to focus on patient care.\nFurthermore, cloud-based technologies facilitate inter-hospital collaboration. Moving away from siloed data centers enables greater data sharing and transparency. This is particularly beneficial for managing pharmaceutical supply chains, which can be unpredictable. Shared visibility can mitigate the risk of hoarding and ensure that critical therapies are available where they are needed most, especially during shortages or emergencies.\nPrioritizing Ethical and Secure Transformation:\nAs hospitals embrace digital transformation, cybersecurity must be a paramount concern. Protecting sensitive patient information and ensuring the reliability and integrity of technology are crucial. Given the increasing sophistication of cyber threats, including AI-driven attacks, hospitals must be vigilant in vetting software and vendors, both new and existing. Legacy systems, often overlooked, also require thorough scrutiny.\nBeyond technology assessment, establishing robust cybersecurity governance, risk, and compliance (GRC) programs and hiring qualified personnel are essential. All vendors should adhere to strict compliance standards.\nWhen implemented thoughtfully and securely, digital transformation can enhance operational efficiency, reduce staff burden, and improve patient care. Ultimately, the greatest success will be measured by the positive impact on the patient experience."
  },
  {
    "objectID": "posts/datah/medical_datactor/longevity/index.html",
    "href": "posts/datah/medical_datactor/longevity/index.html",
    "title": "Chagpt and his Artificial intelligence will make us live longer",
    "section": "",
    "text": "Chagpt and his Artificial intelligence will make us live longer\nOpenAI has recently announced an innovative partnership with Retro Biosciences, a biotech startup dedicated to advancing longevity research. This collaboration has resulted in the creation of GPT-4b Micro, a state-of-the-art AI model designed to expedite biological research focused on extending human lifespans by a decade or more. This initiative reflects a growing trend where artificial intelligence plays a pivotal role in biological and medical sciences, with OpenAI’s latest innovation poised to significantly impact longevity science.\nIntroducing GPT-4b Micro GPT-4b Micro is a specialized variant of OpenAI’s renowned GPT-4 model, tailored specifically for biological data analysis. Unlike the general-purpose GPT-4, this version has undergone extensive training on protein sequence datasets, enabling it to decipher protein interactions and suggest ways to manipulate them for research purposes.\nThe AI focuses primarily on a group of proteins known as the Yamanaka factors. These proteins have the remarkable ability to reprogram mature human skin cells into a more youthful, stem cell-like state. Scientists believe that by fine-tuning the behavior of these proteins, it may be possible to rejuvenate human cells, paving the way for longer lifespans and healthier aging.\nA Novel Approach to Protein Engineering GPT-4b Micro distinguishes itself from other AI models like Google’s AlphaFold through its unique approach to protein engineering. While AlphaFold excels at predicting protein structures, GPT-4b Micro takes a step further by generating novel protein variants for experimental testing. The model uses “few-shot” prompts—akin to how ChatGPT crafts text suggestions—to propose innovative combinations of proteins that might yield significant biological advancements.\nBy analyzing its extensive training data, GPT-4b Micro generates protein designs that researchers can validate experimentally. This methodology offers a transformative perspective, presenting scientists with creative experimental directions that may otherwise have gone unexplored. Essentially, GPT-4b Micro serves as a virtual architect for protein innovation.\nPromising Early Results Initial experiments with GPT-4b Micro have shown encouraging outcomes. Protein variants suggested by the AI have outperformed those designed by human researchers, with some achieving performance improvements of up to 50-fold for specific proteins. While these findings are promising, they require further validation through rigorous testing and peer-reviewed studies.\nShould these results withstand scrutiny, they could represent a major leap forward in longevity science. Enhanced proteins capable of rejuvenating cells may significantly extend human life and healthspan, aligning with Retro Biosciences’ mission to leverage AI in the fight against aging.\nWhy It Matters This development highlights the transformative potential of AI in accelerating discoveries in biology and medicine. OpenAI’s CEO, Sam Altman, has expressed optimism about AI’s ability to drive scientific progress, and GPT-4b Micro exemplifies this vision by contributing to advancements in longevity research.\nNotably, Sam Altman has personally invested $180 million in Retro Biosciences, underscoring the growing interest and importance of this field. The collaboration between AI and biotechnology represents an exciting frontier in addressing humanity’s grand challenges, with profound implications for aging populations and global health.\nLooking Ahead Despite the promising early results, the journey to fully validate and refine GPT-4b Micro’s protein designs remains complex. However, the partnership between OpenAI and Retro Biosciences sets a precedent for integrating AI with biological research to tackle age-related challenges. By combining computational power with scientific inquiry, they are advancing efforts to extend human lifespans and improve the quality of life on an unprecedented scale.\nAs AI continues to revolutionize biological sciences, it is clear that these technologies will play an increasingly critical role in addressing some of humanity’s most pressing issues. While the ultimate impact of GPT-4b Micro on longevity research is yet to be determined, the collaboration between OpenAI and Retro Biosciences marks an important step toward a future where AI-driven solutions reshape our understanding of aging and health."
  }
]